Curi Bio
Curi Bio is a biotechnology company that focuses on advancing drug discovery and development through innovative approaches involving human stem cells, systems biology, and data analytics. The company's primary goal is to accelerate the process of identifying and developing new medicines. Curi Bio's platform revolves around the use of human stem cells, which have the potential to be differentiated into various cell types, replicating the behavior of different tissues and organs. This allows researchers to create more accurate and relevant models for studying disease mechanisms and testing potential drug candidates. NanoSurface Biomedical Is Now Curi Bio.
Domain
curibio.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$10.0M
Founded
2014
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Curi Bio use?+
We have not yet detected technologies for Curi Bio.
What industry is Curi Bio in?+
Curi Bio operates in the Artificial Intelligence (AI) industry.
Where is Curi Bio based?+
Curi Bio is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026